Can the medication in patients with rheumatoidarthritis in remission be stopped?;¿Se puede suspender la medicación en los pacientes con artritis reumatoide en remisión?

Reumatologia Clinica

Volumn 8, Issue 1, 2012, Pages 39-41

  Nóvoa Medina, Francisco Javier ^a   Francisco Hernández, Félix ^b  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

Anti tumor necrosis factor alpha; Disease modifying drugs; Remission; Rheumatoid arthritis

Indexed keywords

METHOTREXATE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; HUMAN; MORBIDITY; MORTALITY; RADIOGRAPHY; REMISSION; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; REMISSION INDUCTION; WITHHOLDING TREATMENT;

EID: 84856271157     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2011.08.003     Document Type: Article

References (15)

1. Smolen J., Landewé R., Breedveld F.C., Dougados M., Emery P., Gaujoux-Viala C., et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010, 69:964-975.
2. Tornero Molina J., Sanmartí R., Rodríguez V., Martín Mola E., Marenco J.L., González I., et al. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide. Reumatol Clin 2010, 6:23-36.
3. Balsa A. ¿Cómo se evalúa una respuesta inadecuada en un paciente con artritis reumatoide en la práctica clínica?. Reumatol Clin 2007, 3:38-44.
4. Felson D.T., Smolen J.F., Wells G., Zhang B., Van Tuyl L.H.D., Funovits J., et al. American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials. Arthritis Rheum 2011, 63:573-586.
5. Saleem B., Brown A.K., Keen H., Parmar R., Nizam S., Hensoret E.M.A., et al. Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments. Ann Rheum Dis 2011, 70:792-798.
6. Finckh A., Liang M.H., Van Herckenrode C.M., De Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a metaanalysis. Arthritis Rheum 2006, 55:864-872.
7. Van der Linden M.P., Le Cessie S., Raza K., Woude D.vd, Knevel R., Huizinga T.W.J., et al. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 2010, 62:3537-3546.
8. Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism Collaborative Initiative. Ann Rheum Dis 2010, 69:1580-1588.
9. Tiippana-Kinnunen T., Paimela L., Kautiainen H., Laasonen L., Leirisalo-Repo M. Can disease-modifying antirheumatic drugs be d iscontinued in long-standing rheumatoid arthritis? A 15-year follow-up. Scand J Rheumatol 2010, 39:12-18.
10. Goekoop-Ruiterman Y.P.M., De Vries-Bouwstra J.K., Allaart C.F., Van Zebe D., Kerstens P.J.S.M., Hazes J.M.W., et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the best study). Arthritis Rheum 2005, 52:3381-3390.
11. Klarenbeek N.B., Van der Kooij SM, Guler-Yuksel M., Van Groenendael J.H.L.M., Han K.H., Kerstens P.J.S.M., et al. Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study. Ann Rheum Dis 2011, 70:315-319.
12. Brocq O., Millasseau E., Albert C., Grisot C., Flory P., Roux C.H., et al. Effect of discontinuing TNFa antagonist therapy in patients with remission of rheumatoid arthritis. Joint Bone Spine 2009, 76:350-355.
13. Tanaka Y., Takeuchi T., Mimori T., Saito K., Nawata M., Kameda H., et al. Discontinuation of infl iximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis 2010, 69:1286-1291. for the RRR study investigators.
14. Saleem B., Keen H., Goeb V., Parmar R., Nizam S., Hensor E.M.A., et al. Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?. Ann Rheum Dis 2010, 69:1636-1642.
15. O'Mahony R., Richards A., Deighton C., Scot D. Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systemic review and meta-analysis. Ann Rheum Dis 2010, 69:1823-1826.